Cymelarsan by Boehringer Ingelheim

Cymelarsan by Boehringer Ingelheim is a specialized injectable solution designed to combat Trypanosoma evansi infections, commonly known as surra, in camels. The active ingredient, melarsamine hydrochloride, exhibits rapid trypanocidal activity, effectively eliminating the parasites within hours of administration. This treatment is suitable for acute, subacute, and chronic stages of the disease, promoting swift recovery and minimizing the risk of transmission. Cymelarsan is well-tolerated and can be safely used in pregnant animals, making it a reliable choice for maintaining the health and productivity of camel herds.

Usage:

• Administration Route: Deep intramuscular injection in the neck.

• Dosage: 0.25 mg/kg body weight, equivalent to 2.5 ml per 50 kg body weight.

• Preparation: Dissolve the freeze-dried powder in 20 ml of sterile water to prepare a 0.5% solution at the time of use.

• Note: For small or emaciated camels, split the volume into two injection sites (right and left side of the neck). Always consult a veterinarian for precise dosing and administration guidance.

Benefits:

• Rapid Action: Destroys trypanosomes within hours, leading to quick recovery.

• Broad Efficacy: Effective against various stages of T. evansi infection.

• Safe for Pregnant Animals: Can be administered without risk during pregnancy.

• Well-Tolerated: Minimal side effects, with occasional slight swelling at the injection site that resolves within days.

• Proven Effectiveness: Backed by Boehringer Ingelheim’s commitment to quality and veterinary health.